Day Hospitals Reinvented : the future of Parkinson’s care
Objective: To evaluate our model of delivering inter-disciplinary, patient-focused care in an outpatient environment. Background: The progressive and potential debilitating nature of Parkinson’s makes early…Accelerometer-Based Gait Analysis for Patients with Parkinson’s Disease
Objective: The study is to develop an accelerometer-based gait analysis for the patients with Parkinson’s disease, which would provide timely complete gait information following the…Systematic review of Mucuna Pruriens as a treatment for Parkinson’s disease
Objective: To conduct a systematic review of the therapeutic evidence for Mucuna Pruriens (MP) in the treatment of Parkinson’s disease (PD). Background: MP or Velvet bean is a…Efficacy of carbidopa/levodopa enteral suspension (CLES) in advanced Parkinson’s disease patients previously treated with deep brain stimulation (DBS) – A subgroup analysis from PROviDE study
Objective: To evaluate the effectiveness of carbidopa/levodopa enteral suspension (CLES) on patients with advanced Parkinson’s disease who had previously undergone deep brain stimulation (DBS). Background:…Evaluation of swallowing function by video-fluorography in patients with parkinsonism
Objective: The purpose of the present study is to investigate characteristic patterns of swallowing problems in each clinical entity of parkinsonism including Parkinson’s disease (PD)…Asymmetry of motor symptoms in patients with Parkinson’s Disease
Objective: The objective of our research was to investigate the asymmetry of motor symptoms in patients with Parkinson’s Disease (PD). Background: In most PD cases…Treating Depression in Parkinson’s Disease: a Systematic Literature Review
Objective: To elucidate the most acceptable and effective treatments for the management of depression in Parkinson’s disease (PD) using a systematic review approach. Background: Depression…Associations of microtubule associated protein tau (MAPT) H1 subhaplotypes and the MAPT H2 haplotype with demographic and clinical features in Parkinson`s disease
Objective: To assess associations of microtubule associated protein tau (MAPT) H1 subhaplotypes and the H2 haplotype with clinical features in patients with Parkinson`s disease (PD).…Alpha-synuclein promoter (SNCA-Rep1) polymorphism is associated with non-motor symptoms in early Parkinson’s disease
Objective: We sought to investigate the relationship between SNCA Rep1 allele length and NMS in PD. Background: Associations between the alpha-synuclein gene (SNCA) promoter region…The longevity gene Klotho and its CSF protein profiles as modifier for Parkinson´s disease in a longitudinal study
Objective: Our objective was to evaluate phenotype modifying effects of variants in longevity genes in PD. Background: Parkinson´s disease (PD) has a large phenotypic variability,…
- « Previous Page
- 1
- …
- 155
- 156
- 157
- 158
- 159
- …
- 405
- Next Page »